Pharmaceutical compositions with attenuated release of phenolic opioids

Details for Australian Patent Application No. 2009305563 (hide)

Owner PharmacoFore, Inc.

Inventors Jenkins, Thomas E.; Seroogy, Julie D.; Wray, Jonathan W.

Agent FB Rice

Pub. Number AU-A-2009305563

PCT Pub. Number WO2010/045599

Priority 61/106,400 17.10.08 US

Filing date 16 October 2009

Wipo publication date 22 April 2010

International Classifications

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

28 April 2011 PCT application entered the National Phase

  PCT publication WO2010/045599 Priority application(s): WO2010/045599

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009305565-Synergistic combination of sphingosine1-phosphate receptor antagonists and antimicrotubule agents

2009305550-MUC-1 cytoplasmic domain peptides as inhibitors of cancer